Analysts: Walgreens May Beat Earnings Expectations and 3 Other Research Notes to Explore

Walgreens (NYSE:WAG): Citigroup expects Walgreens to report fourth quarter earnings of $0.75 per share, above the consensus estimate of $0.57 per share. The firm raised its price target for the shares to $63 from $57, and it reiterates a Buy rating on the stock.

WAG 20130930

Regeneron (NASDAQ:REGN): Piper Jaffray believes that Regeneron’s Phase III data on EYLEA in Diabetic Macular Edema that was presented over the weekend supports label expansion with blockbuster potential. Piper raised its price target for the shares to $360 from $336, and the firm reiterates an Overweight rating on the stock.

REGN 20130930

WhiteWave Foods (NYSE:WWAV): BMO Capital downgraded WhiteWave Foods to Underperform from Market Perform based on expectations for a meaningful deceleration in sales in 2014 and 2015 due to increased competition, changing consumer preferences, and moderating organic milk single-serve consumption trends. The shares’ price target is $17.

WWAV 20130930

ARIAD (NASDAQ:ARIA): BMO Capital downgraded ARIAD to Market Perform from Outperform due to disappointing AP26113 data and unfavorable expert feedback regarding competitive positioning. The shares’ price target has been lowered to $21 from $37. On the other hand, Oppenheimer upgraded shares this morning.

ARIA 20130930

Don’t Miss: This Union Isn’t Happy With DoJ Suit Against American-US Airways.

More from The Cheat Sheet